Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Hemostasis  [Clear All Filters]
2018
Ward-Caviness CK, Huffman JE, Everett K, et al. "DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis." Blood. 2018;132(17):1842-1850.
2017
Pankow JS, Tang W, Pankratz N, et al. "Identification of Genetic Variants Linking Protein C and Lipoprotein Metabolism: The ARIC Study (Atherosclerosis Risk in Communities)." Arterioscler Thromb Vasc Biol. 2017;37(3):589-597.
2016
Cushman M, O'Meara ES, Heckbert SR, Zakai NA, Rosamond WD. "Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology." Thromb Res. 2016;144:127-32.
2013
Wang QY, Song J, Gibbs RA, Boerwinkle E, Dong JF, Yu FL. "Characterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes." J Thromb Haemost. 2013;11(2):261-9.
2010
Smith NL, Chen M-H, Dehghan A, et al. "Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium." Circulation. 2010;121(12):1382-92.
Suri FMK, Yamagishi K, Aleksic N, Hannan PJ, Folsom AR. "Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study." Cerebrovasc Dis. 2010;29(5):497-502.
2009
Kucharska-Newton AM, Couper DJ, Pankow JS, et al. "Hemostasis, inflammation, and fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in communities (ARIC) cohort." Arterioscler Thromb Vasc Biol. 2009;29(12):2182-90.
Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. "Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study." Am J Kidney Dis. 2009;53(4):596-605.
2007
Reich LM, Heiss G, Boland LL, Hirsch AT, Wu K, Folsom AR. "Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort." Vasc Med. 2007;12(4):267-73.
2005
Liao D, Heiss G, Chinchilli VM, et al. "Association of criteria pollutants with plasma hemostatic/inflammatory markers: a population-based study." J Expo Anal Environ Epidemiol. 2005;15(4):319-28.
2003
Miller EA, Pankow JS, Millikan RC, et al. "Glutathione-S-transferase genotypes, smoking, and their association with markers of inflammation, hemostasis, and endothelial function: the atherosclerosis risk in communities (ARIC) study." Atherosclerosis. 2003;171(2):265-72.
2002
Schreiner PJ, Wu KK, M Malinow R, et al. "Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study." Ann Epidemiol. 2002;12(4):228-36.
2001
Knuiman MW, Folsom AR, Chambless LE, Liao D, Wu KK. "Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study." Neuroepidemiology. 2001;20(2):96-104.
2000
Metcalf PA, Folsom AR, Davis CE, Wu KK, Heiss G. "Haemostasis and carotid artery wall thickness in non-insulin dependent diabetes mellitus." Diabetes Res Clin Pract. 2000;47(1):25-35.
1999
Duncan BB, Schmidt MI, Offenbacher S, Wu KK, Savage PJ, Heiss G. "Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study." Diabetes Care. 1999;22(5):767-72.
Folsom AR. ""New" risk factors for atherosclerotic diseases." Exp Gerontol. 1999;34(4):483-90.
Folsom AR, Rosamond WD, Shahar E, et al. "Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Circulation. 1999;100(7):736-42.
1997
Nieto FJ, Sorlie P, Comstock GW, et al. "Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link?" Arterioscler Thromb Vasc Biol. 1997;17(9):1780-5.
1995
Nguyen ND, Ghaddar H, Stinson V, Chambless LE, Wu KK. "ARIC hemostasis study--IV. Intraindividual variability and reliability of hemostatic factors. The Atherosclerosis Risk in Communities (ARIC)." Thromb Haemost. 1995;73(2):256-60.
Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalf PA, Barnes RW. "Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima-media thickness. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Ann Epidemiol. 1995;5(3):186-91.
1993
Chambless LE, McMahon R, Finch A, et al. "ARIC hemostasis study--III. Quality control. Atherosclerosis Risk in Communities." Thromb Haemost. 1993;70(4):588-94.
Folsom AR, Wu KK, Shahar E, Davis CE. "Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators." Arterioscler Thromb. 1993;13(12):1829-36.
1992
Sharrett AR. "The Atherosclerosis Risk in Communities (ARIC) Study. Introduction and objectives of the hemostasis component." Ann Epidemiol. 1992;2(4):467-9.
Folsom AR, Conlan MG, Davis CE, Wu KK. "Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators." Ann Epidemiol. 1992;2(4):481-94.
Chambless LE, McMahon R, Wu K, Folsom A, Finch A, Shen YL. "Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study." Ann Epidemiol. 1992;2(5):723-33.
1990
Wu KK, Papp AC, Patsch W, Rock R, Eckfeldt J, Sharrett R. "ARIC hemostasis study--II. Organizational plan and feasibility study." Thromb Haemost. 1990;64(4):521-5.
1989
Papp AC, Hatzakis H, Bracey A, Wu KK. "ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies." Thromb Haemost. 1989;61(1):15-9.